희귀질환 등록 시장 보고서(2026년)

Rare disease registries are structured databases that systematically collect and maintain information on patients with rare medical conditions. They allow longitudinal monitoring of disease progression, treatment outcomes, and epidemiological trends. These registries support research, clinical decision-making, and therapeutic development by providing consistent, reliable patient data.

The key types of rare disease registries include product registries, health services registries, and disease registries. Product registries are organized databases tracking patient outcomes and safety information for specific therapies or interventions. Database types include population-based and hospital-based, with software options including standalone and integrated solutions. Functions include data collection, data analysis, patient recruitment, and others, serving pharmaceutical companies, research organizations, hospitals, government agencies, and other end-users.

Tariffs have influenced the rare disease registries market by increasing the costs of importing advanced registry software, data management tools, and analytic platforms. This impact is most notable in segments such as software and integrated registry solutions, particularly in regions like North America and Europe with high reliance on imported technologies. While tariffs may slow adoption and increase operational costs, they also encourage local development of registry solutions, fostering innovation, cost optimization, and resilience in the market.

The rare disease registries market research report is one of a series of new reports from The Business Research Company that provides rare disease registries market statistics, including rare disease registries industry global market size, regional shares, competitors with a rare disease registries market share, detailed rare disease registries market segments, market trends and opportunities, and any further data you may need to thrive in the rare disease registries industry. This rare disease registries market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rare disease registries market size has grown rapidly in recent years. It will grow from $1.62 billion in 2025 to $1.82 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rising awareness of rare diseases, increasing clinical research activities, growth in hospital and population-based registries, regulatory support for patient data collection, limited availability of structured patient data.

The rare disease registries market size is expected to see rapid growth in the next few years. It will grow to $2.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to adoption of ai-driven registry solutions, integration with genomic and omics data, expansion of personalized medicine initiatives, investment in cloud-based interoperable platforms, enhanced patient engagement and data sharing. Major trends in the forecast period include real-time patient data collection, integration with electronic health records (ehr), advanced data analytics for rare diseases, patient recruitment and retention optimization, interoperable registry platforms.

The growing government initiatives and funding support are expected to fuel the expansion of the rare disease registries market over the forecast period. Government initiatives and funding support include public programs and financial investments aimed at strengthening healthcare infrastructure, encouraging innovation, and improving service delivery. Rising public funding reflects efforts to enhance data-driven policymaking, optimize resource allocation, and improve outcomes for underserved patient populations, including individuals with rare diseases. Rare disease registries are pivotal in achieving these objectives by aggregating comprehensive patient data that guide policy decisions, enable targeted funding allocation, and support the design and evaluation of effective healthcare and research programs. For instance, in February 2025, the UK government's central executive authority committed around £26 billion ($35 billion) over two years to support the health and care system, emphasizing investment in data infrastructure and population health initiatives. Therefore, growing government initiatives and funding support are driving the growth of the rare disease registries market.

Key companies operating in the rare disease registries market are focusing on developing advanced products such as, an AI-enabled patient registry infrastructure to enhance real-time data capture, patient monitoring, and research insights across rare diseases. AI-enabled patient registry infrastructure refers to registry systems that leverage artificial intelligence to process, analyze, and interpret large-scale patient and clinical data efficiently, enabling predictive analytics, natural history modeling, and real-world evidence generation. For example, in May 2024, National Organization for Rare Disorders (NORD), a US-based non-profit advocacy organization dedicated to individuals with rare diseases and the organizations that serve them, launched the first Canadian rare disease patient registries on its IAMRARE platform for phenylketonuria (PKU) and mucopolysaccharidoses (MPS), allowing real-time cooperative data collection, supporting multiple languages and regional consent requirements, and providing valuable insights for clinical trial eligibility, disease progression tracking, and treatment evaluation.

In October 2023, IQVIA Holdings Inc., a US-based provider of healthcare data, analytics, and technology solutions, acquired Open Applications Consulting Limited (OpenApp) for an undisclosed amount. Through this acquisition, IQVIA enhanced its capabilities in patient registry software and real-world evidence solutions, improving its ability to build, deploy, and scale disease-specific registries by integrating OpenApp's customizable registry platforms to support longitudinal data capture, research insights, and clinical program needs across rare and chronic conditions. Open Applications Consulting Limited (OpenApp) is an Ireland-based health technology company developing patient registry and health intelligence software used to collect and manage disease-specific clinical and real-world data, including platforms for rare disease and low-prevalence condition registries.

Major companies operating in the rare disease registries market are disease registries market are Deloitte Touche Tohmatsu Limited, International Business Machines Corporation, Oracle Corporation, BC Platforms Ltd., IQVIA Holdings Inc., ICON plc, Veeva Systems Inc., Alira Health Inc., Phastar Ltd., HealthVerity Inc., OM1 Inc., Synapse Laboratory, Castor EDC, RedCap Cloud, Within3 Inc., Sage Bionetworks, National Organization for Rare Disorders Inc., RTI Health Solutions, ArborMetrix Inc., Evado Clinical Systems Ltd., ClinCapture LLC, Global Vision Technologies Inc., Genetic Alliance UK, Pulse Infoframe.

North America was the largest region in the rare disease registries market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease registries market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rare disease registries market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rare disease registries market includes revenues earned by entities through epidemiological tracking, outcomes monitoring, and data quality assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rare Disease Registries Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses rare disease registries market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rare disease registries ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rare disease registries market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Product Registries; Health Services Registries; Disease Registries
• 2) By Database Type: Population-based; Hospital-based
• 3) By Software: Standalone; Integrated
• 4) By Function: Data Collection; Data Analysis; Patient Recruitment; Other Functions
• 5) By End-User: Pharmaceutical Companies; Research Organizations; Hospitals; Government Agencies; Other End-Users
• Subsegments:
• 1) By Product Registries: Drug Product Registries; Biologic Product Registries; Medical Device Registries; Gene Therapy Product Registries
• 2) By Health Services Registries: Hospital Based Registries; Clinic Based Registries; National Health Program Registries; Insurance Claims Registries
• 3) By Disease Registries: Genetic Disorder Registries; Metabolic Disorder Registries; Neurological Disorder Registries; Oncology Rare Disease Registries
• Companies Mentioned: Deloitte Touche Tohmatsu Limited; International Business Machines Corporation; Oracle Corporation; BC Platforms Ltd.; IQVIA Holdings Inc.; ICON plc; Veeva Systems Inc.; Alira Health Inc.; Phastar Ltd.; HealthVerity Inc.; OM1 Inc.; Synapse Laboratory; Castor EDC; RedCap Cloud; Within3 Inc.; Sage Bionetworks; National Organization for Rare Disorders Inc.; RTI Health Solutions; ArborMetrix Inc.; Evado Clinical Systems Ltd.; ClinCapture LLC; Global Vision Technologies Inc.; Genetic Alliance UK; Pulse Infoframe.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Rare Disease Registries Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Rare Disease Registries Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Rare Disease Registries Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Rare Disease Registries Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Real-Time Patient Data Collection
  • 4.2.2 Integration With Electronic Health Records (Ehr)
  • 4.2.3 Advanced Data Analytics For Rare Diseases
  • 4.2.4 Patient Recruitment And Retention Optimization
  • 4.2.5 Interoperable Registry Platforms

5. Rare Disease Registries Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Research Organizations
• 5.3 Hospitals
• 5.4 Government Agencies
• 5.5 Clinical Trial Organizations

6. Rare Disease Registries Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rare Disease Registries Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Rare Disease Registries PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Rare Disease Registries Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Rare Disease Registries Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Rare Disease Registries Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rare Disease Registries Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rare Disease Registries Market Segmentation

• 9.1. Global Rare Disease Registries Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Product Registries, Health Services Registries, Disease Registries
• 9.2. Global Rare Disease Registries Market, Segmentation By Database Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Population-based, Hospital-based
• 9.3. Global Rare Disease Registries Market, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Standalone, Integrated
• 9.4. Global Rare Disease Registries Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Data Collection, Data Analysis, Patient Recruitment, Other Functions
• 9.5. Global Rare Disease Registries Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Companies, Research Organizations, Hospitals, Government Agencies, Other End-Users
• 9.6. Global Rare Disease Registries Market, Sub-Segmentation Of Product Registries, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug Product Registries, Biologic Product Registries, Medical Device Registries, Gene Therapy Product Registries
• 9.7. Global Rare Disease Registries Market, Sub-Segmentation Of Health Services Registries, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Based Registries, Clinic Based Registries, National Health Program Registries, Insurance Claims Registries
• 9.8. Global Rare Disease Registries Market, Sub-Segmentation Of Disease Registries, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Genetic Disorder Registries, Metabolic Disorder Registries, Neurological Disorder Registries, Oncology Rare Disease Registries

10. Rare Disease Registries Market Regional And Country Analysis

• 10.1. Global Rare Disease Registries Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Rare Disease Registries Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rare Disease Registries Market

• 11.1. Asia-Pacific Rare Disease Registries Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rare Disease Registries Market

• 12.1. China Rare Disease Registries Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rare Disease Registries Market

• 13.1. India Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rare Disease Registries Market

• 14.1. Japan Rare Disease Registries Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rare Disease Registries Market

• 15.1. Australia Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rare Disease Registries Market

• 16.1. Indonesia Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rare Disease Registries Market

• 17.1. South Korea Rare Disease Registries Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rare Disease Registries Market

• 18.1. Taiwan Rare Disease Registries Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rare Disease Registries Market

• 19.1. South East Asia Rare Disease Registries Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rare Disease Registries Market

• 20.1. Western Europe Rare Disease Registries Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rare Disease Registries Market

• 21.1. UK Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rare Disease Registries Market

• 22.1. Germany Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rare Disease Registries Market

• 23.1. France Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rare Disease Registries Market

• 24.1. Italy Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rare Disease Registries Market

• 25.1. Spain Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rare Disease Registries Market

• 26.1. Eastern Europe Rare Disease Registries Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rare Disease Registries Market

• 27.1. Russia Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rare Disease Registries Market

• 28.1. North America Rare Disease Registries Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rare Disease Registries Market

• 29.1. USA Rare Disease Registries Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rare Disease Registries Market

• 30.1. Canada Rare Disease Registries Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rare Disease Registries Market

• 31.1. South America Rare Disease Registries Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rare Disease Registries Market

• 32.1. Brazil Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rare Disease Registries Market

• 33.1. Middle East Rare Disease Registries Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rare Disease Registries Market

• 34.1. Africa Rare Disease Registries Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Rare Disease Registries Market, Segmentation By Type, Segmentation By Database Type, Segmentation By Software, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rare Disease Registries Market Regulatory and Investment Landscape

36. Rare Disease Registries Market Competitive Landscape And Company Profiles

• 36.1. Rare Disease Registries Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Rare Disease Registries Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Rare Disease Registries Market Company Profiles
  • 36.3.1. Deloitte Touche Tohmatsu Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. BC Platforms Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Rare Disease Registries Market Other Major And Innovative Companies

• ICON plc, Veeva Systems Inc., Alira Health Inc., Phastar Ltd., HealthVerity Inc., OM1 Inc., Synapse Laboratory, Castor EDC, RedCap Cloud, Within3 Inc., Sage Bionetworks, National Organization for Rare Disorders Inc., RTI Health Solutions, ArborMetrix Inc., Evado Clinical Systems Ltd.

38. Global Rare Disease Registries Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Rare Disease Registries Market

41. Rare Disease Registries Market High Potential Countries, Segments and Strategies

• 41.1 Rare Disease Registries Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Rare Disease Registries Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Rare Disease Registries Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer